BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY OUR PLATFORMS
Endocrine-disrupting chemicals (EDCs) are organic and inorganic compounds that affect various hormone-regulated physiological pathways in humans and wildlife. EDCs are produced as plasticizers, pesticides, detergents, and pharmaceutical compounds, and nowadays are widely spread around the globe. Their actions have been associated with reproductive dysfunction, obesity, cancer, and developmental anomalies. Because hormone receptors are highly conserved among vertebrates and particularly responsive in fish, zebrafish embryos are an excellent tool for screening EDCs.
Exposure to EDCs has consequences at different biological levels: from changes in molecular patterns to adverse effects at the organism or population level. Changes at the transcriptomic level (messenger RNA content, mRNA) have been identified as biomarkers of EDC exposure, with a number of potential candidates under evaluation. Cost-effective methodologies with low variation, which allow spatial and temporal measurements and can be used in high throughput, are necessary for chemical screening.
Our endocrine disruption assay is performed in embryonic zebrafish and represents a 3Rs-aligned alternative for rapid, informative, and high throughput screenings.
In vivo high throughput screening platform to evaluate endocrine-disrupting compounds.
Evaluation of disrupting effects in a complete organism.Specific or simultaneous evaluation of impact in the three major endocrine pathways (estrogens, androgens and thyroid) in only one assay.Applicable to a wide range of compounds, including mixtures. Determination of anti-estrogenic and anti-androgenic effects.
Evaluation of disrupting effects in a complete organism.
Specific or simultaneous evaluation of impact in the three major endocrine pathways (estrogens, androgens and thyroid) in only one assay.
Applicable to a wide range of compounds, including mixtures.
Determination of anti-estrogenic and anti-androgenic effects.
Zebrafish embryos are exposed to the molecule of interest and the three endocrine pathways are assessed individually or simultaneously through transcriptional analysis of a panel of validated gene expression biomarkers. The disruption can be evaluated as activation or repression of the pathway.
Determination of the following activities measured as fold induction compared to controls at 120 hpf:
If you want more information about our endocrinedisruption assay or have any other questions, please contact our experts.